FDA Inspection 1182088 — Randy J. Epstein, M.D.

Randy J. Epstein, M.D. — FEI 3002686308

The FDA completed an inspection of Randy J. Epstein, M.D. on October 26, 2022 in Highland Park, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 26, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Highland Park, IL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
722721 CFR 50.27(a)Consent form not approved/signed/dated
745921 CFR 312.57(a)Records of receipt, shipment, disposition
752621 CFR 312.62(a)Accountability records
763821 CFR 312.20(a)Failure to submit an IND